ARTICLE | Company News
Cristal Therapeutics, PX Biosolutions deal
August 24, 2015 7:00 AM UTC
The companies will combine Cristal’s CriVac technology and PX’s DCtag vaccine formulation to develop cancer vaccines. The CriVac technology uses polymeric nanoparticles to facilitate optimal antigen p...